Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Hamroun A, Lenain R, Bigna JJ, Speyer E, Bui L, Chamley P, Pottier N, Cauffiez C, Dewaeles E, Dhalluin X, Scherpereel A, Hazzan M, Maanaoui M, Glowacki F.

Drugs. 2019 Aug 19. doi: 10.1007/s40265-019-01182-1. [Epub ahead of print] Review.

PMID:
31429065
2.

Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis.

Van der Hauwaert C, Glowacki F, Pottier N, Cauffiez C.

Int J Mol Sci. 2019 Apr 23;20(8). pii: E1977. doi: 10.3390/ijms20081977. Review.

3.

The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.

Savary G, Dewaeles E, Diazzi S, Buscot M, Nottet N, Fassy J, Courcot E, Henaoui IS, Lemaire J, Martis N, Van der Hauwaert C, Pons N, Magnone V, Leroy S, Hofman V, Plantier L, Lebrigand K, Paquet A, Lino Cardenas CL, Vassaux G, Hofman P, Günther A, Crestani B, Wallaert B, Rezzonico R, Brousseau T, Glowacki F, Bellusci S, Perrais M, Broly F, Barbry P, Marquette CH, Cauffiez C, Mari B, Pottier N.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):184-198. doi: 10.1164/rccm.201807-1237OC.

PMID:
30964696
4.

Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.

Teissier T, Quersin V, Gnemmi V, Daroux M, Howsam M, Delguste F, Lemoine C, Fradin C, Schmidt AM, Cauffiez C, Brousseau T, Glowacki F, Tessier FJ, Boulanger E, Frimat M.

Aging Cell. 2019 Apr;18(2):e12850. doi: 10.1111/acel.12850. Epub 2019 Feb 22.

5.

Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation.

Vandenbussche C, Van der Hauwaert C, Dewaeles E, Franczak J, Hennino MF, Gnemmi V, Savary G, Tavernier Q, Nottet N, Paquet A, Perrais M, Blum D, Mari B, Pottier N, Glowacki F, Cauffiez C.

Arch Toxicol. 2018 Apr;92(4):1539-1550. doi: 10.1007/s00204-018-2158-3. Epub 2018 Jan 23.

PMID:
29362864
6.

Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.

Gaudelot K, Gibier JB, Pottier N, Hémon B, Van Seuningen I, Glowacki F, Leroy X, Cauffiez C, Gnemmi V, Aubert S, Perrais M.

Tumour Biol. 2017 Jul;39(7):1010428317707372. doi: 10.1177/1010428317707372.

PMID:
28714373
7.

Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase.

Gibier JB, Hémon B, Fanchon M, Gaudelot K, Pottier N, Ringot B, Van Seuningen I, Glowacki F, Cauffiez C, Blum D, Copin MC, Perrais M, Gnemmi V.

Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1336-1349. doi: 10.1016/j.bbadis.2017.03.023. Epub 2017 Mar 31.

8.

miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.

Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noël C, Cauffiez C, Glowacki F.

Sci Rep. 2016 Jun 6;6:27209. doi: 10.1038/srep27209.

9.

[MicroRNAs in kidney fibrosis].

Van der Hauwaert C, Savary G, Hennino MF, Pottier N, Glowacki F, Cauffiez C.

Nephrol Ther. 2015 Nov;11(6):474-82. doi: 10.1016/j.nephro.2015.03.007. Epub 2015 Jul 26. Review. French.

PMID:
26216507
10.

Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation.

Van der Hauwaert C, Savary G, Pinçon C, Gnemmi V, Noël C, Broly F, Labalette M, Perrais M, Pottier N, Glowacki F, Cauffiez C.

Fibrogenesis Tissue Repair. 2015 May 5;8:8. doi: 10.1186/s13069-015-0025-x. eCollection 2015.

11.

Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients.

Bloch J, Hazzan M, Van der Hauwaert C, Buob D, Savary G, Hertig A, Gnemmi V, Frimat M, Perrais M, Copin MC, Broly F, Noël C, Pottier N, Cauffiez C, Glowacki F.

Pharmacogenomics. 2014 Dec;15(16):2011-24. doi: 10.2217/pgs.14.146.

PMID:
25521359
12.

Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models.

Van der Hauwaert C, Savary G, Buob D, Leroy X, Aubert S, Flamand V, Hennino MF, Perrais M, Lo-Guidice JM, Broly F, Cauffiez C, Glowacki F.

Toxicol Appl Pharmacol. 2014 Sep 15;279(3):409-18. doi: 10.1016/j.taap.2014.07.007. Epub 2014 Jul 15.

PMID:
25036895
13.

FibromiRs: translating molecular discoveries into new anti-fibrotic drugs.

Pottier N, Cauffiez C, Perrais M, Barbry P, Mari B.

Trends Pharmacol Sci. 2014 Mar;35(3):119-26. doi: 10.1016/j.tips.2014.01.003. Epub 2014 Feb 19. Review.

PMID:
24560301
14.

MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.

Bouillez A, Gnemmi V, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Butruille C, Cauffiez C, Hamdane M, Sergeant N, Van Seuningen I, Leroy X, Aubert S, Perrais M.

Oncotarget. 2014 Feb 15;5(3):754-63.

15.

MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.

Gnemmi V, Bouillez A, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Villers A, Vindrieux D, Cauffiez C, Van Seuningen I, Bernard D, Leroy X, Aubert S, Perrais M.

Cancer Lett. 2014 May 1;346(2):225-36. doi: 10.1016/j.canlet.2013.12.029. Epub 2013 Dec 30.

PMID:
24384091
16.

Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10/CD13 double labeling.

Van der Hauwaert C, Savary G, Gnemmi V, Glowacki F, Pottier N, Bouillez A, Maboudou P, Zini L, Leroy X, Cauffiez C, Perrais M, Aubert S.

PLoS One. 2013 Jun 14;8(6):e66750. doi: 10.1371/journal.pone.0066750. Print 2013.

17.

[miR-199a-5p in idiopathic pulmonary fibrosis].

Henaoui IS, Cauffiez C, Aubert S, Buscot M, Dewaeles E, Copin MC, Marquette CH, Barbry P, Perrais M, Pottier N, Mari B.

Med Sci (Paris). 2013 May;29(5):461-3. doi: 10.1051/medsci/2013295006. Epub 2013 May 28. French. No abstract available.

18.

Increased circulating miR-21 levels are associated with kidney fibrosis.

Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouyé S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C.

PLoS One. 2013;8(2):e58014. doi: 10.1371/journal.pone.0058014. Epub 2013 Feb 28.

19.

miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.

Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N.

PLoS Genet. 2013;9(2):e1003291. doi: 10.1371/journal.pgen.1003291. Epub 2013 Feb 14.

20.

Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.

Lino Cardenas CL, Renault N, Farce A, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Chavatte P, Broly F, Chevalier D.

Gene. 2011 Nov 1;487(1):10-20. doi: 10.1016/j.gene.2011.07.015. Epub 2011 Jul 27.

PMID:
21820496

Supplemental Content

Loading ...
Support Center